Annual Retained Earnings
-$335.13 M
-$31.31 M-10.31%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual retained earnings is -$335.13 million, with the most recent change of -$31.31 million (-10.31%) on December 31, 2023.
- During the last 3 years, AVTX annual retained earnings has fallen by -$157.34 million (-88.50%).
- AVTX annual retained earnings is now -1140.42% below its all-time high of -$27.02 million, reached on December 31, 2013.
Performance
AVTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$334.92 M
+$23.04 M+6.44%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly retained earnings is -$334.92 million, with the most recent change of +$23.04 million (+6.44%) on September 30, 2024.
- Over the past year, AVTX quarterly retained earnings has increased by +$23.04 million (+6.44%).
- AVTX quarterly retained earnings is now -677.57% below its all-time high of -$43.07 million, reached on December 31, 2014.
Performance
AVTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AVTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | +6.4% |
| 3 y3 years | -88.5% | -10.2% |
| 5 y5 years | -241.2% | -188.9% |
AVTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.8% | at low | -27.8% | +26.6% |
| 5 y | 5-year | -193.2% | at low | -193.1% | +26.6% |
| alltime | all time | -1140.4% | at low | -677.6% | +26.6% |
Avalo Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$334.92 M(-6.4%) |
| Jun 2024 | - | -$357.96 M(-21.6%) |
| Mar 2024 | - | -$456.42 M(+36.2%) |
| Dec 2023 | -$335.13 M(+10.3%) | -$335.13 M(+2.5%) |
| Sep 2023 | - | -$326.97 M(+1.6%) |
| Jun 2023 | - | -$321.74 M(+2.5%) |
| Mar 2023 | - | -$313.78 M(+3.3%) |
| Dec 2022 | -$303.82 M(+15.9%) | -$303.82 M(+3.3%) |
| Sep 2022 | - | -$294.01 M(-1.1%) |
| Jun 2022 | - | -$297.20 M(+4.6%) |
| Mar 2022 | - | -$284.22 M(+8.4%) |
| Dec 2021 | -$262.17 M(+47.5%) | -$262.17 M(+7.9%) |
| Sep 2021 | - | -$242.97 M(+7.7%) |
| Jun 2021 | - | -$225.57 M(+8.2%) |
| Mar 2021 | - | -$208.47 M(+17.3%) |
| Dec 2020 | -$177.79 M(+55.6%) | -$177.79 M(+9.6%) |
| Sep 2020 | - | -$162.15 M(+9.1%) |
| Jun 2020 | - | -$148.69 M(+9.8%) |
| Mar 2020 | - | -$135.41 M(+18.5%) |
| Dec 2019 | -$114.29 M | -$114.29 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -$115.91 M(+3.6%) |
| Jun 2019 | - | -$111.90 M(+5.9%) |
| Mar 2019 | - | -$105.67 M(+7.6%) |
| Dec 2018 | -$98.22 M(+68.9%) | -$98.22 M(+6.0%) |
| Sep 2018 | - | -$92.66 M(+36.2%) |
| Jun 2018 | - | -$68.06 M(+9.7%) |
| Mar 2018 | - | -$62.05 M(+6.7%) |
| Dec 2017 | -$58.17 M(-16.9%) | -$58.17 M(+5.6%) |
| Sep 2017 | - | -$55.07 M(-25.4%) |
| Jun 2017 | - | -$73.79 M(+2.5%) |
| Mar 2017 | - | -$72.00 M(+2.8%) |
| Dec 2016 | -$70.04 M(+30.8%) | -$70.04 M(+2.4%) |
| Sep 2016 | - | -$68.40 M(+9.9%) |
| Jun 2016 | - | -$62.23 M(+6.0%) |
| Mar 2016 | - | -$58.70 M(+9.6%) |
| Dec 2015 | -$53.56 M(+24.4%) | -$53.56 M(+7.3%) |
| Sep 2015 | - | -$49.91 M(+1.4%) |
| Jun 2015 | - | -$49.22 M(+6.3%) |
| Mar 2015 | - | -$46.31 M(+7.5%) |
| Dec 2014 | -$43.07 M(+59.4%) | -$43.07 M |
| Dec 2013 | -$27.02 M | - |
FAQ
- What is Avalo Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Avalo Therapeutics?
- What is Avalo Therapeutics annual retained earnings year-on-year change?
- What is Avalo Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly retained earnings year-on-year change?
What is Avalo Therapeutics annual retained earnings?
The current annual retained earnings of AVTX is -$335.13 M
What is the all time high annual retained earnings for Avalo Therapeutics?
Avalo Therapeutics all-time high annual retained earnings is -$27.02 M
What is Avalo Therapeutics annual retained earnings year-on-year change?
Over the past year, AVTX annual retained earnings has changed by -$31.31 M (-10.31%)
What is Avalo Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AVTX is -$334.92 M
What is the all time high quarterly retained earnings for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly retained earnings is -$43.07 M
What is Avalo Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AVTX quarterly retained earnings has changed by +$23.04 M (+6.44%)